December 05, 2022 Could a Cheap Liver Drug Prevent or Treat COVID? December 05, 2022/ F. Perry Wilson Ursodeoxycholic acid (UDCA) – Actigall – is a dark horse candidate for a COVID treatment, made more plausible by a series of elegant experiments in new study.Read More
November 29, 2022 Surprising: Vitamin D Does Not Promote Growth in Deficient Kids November 29, 2022/ F. Perry Wilson Randomized trial of over 8000 kids disappoints.Read More
November 22, 2022 Keeping People Out of Sports Stadiums May Have Reduced COVID Cases November 22, 2022/ F. Perry Wilson A new study makes sense, but the analysis is missing some important controls.Read More
November 15, 2022 Understanding that New England Journal Masking In Schools Study November 15, 2022/ F. Perry Wilson Nicely analyzed data suggests lifting mask mandates in schools led to higher infection rates.Read More
November 08, 2022 Which COVID mRNA Vaccine Has the Lowest Risk of Myocarditis? November 08, 2022/ F. Perry Wilson A new study suggests myocarditis rate much higher with Moderna vs. Pfizer vaccine.Read More
October 26, 2022 Ivermectin for COVID: Final Nail in the Coffin? October 26, 2022/ F. Perry Wilson The US-based “ACTIV-6” study showed no effect of the drug on time-to-recovery for outpatients with COVID-19.Read More
October 18, 2022 Five Days of Isolation For COVID is Not Good Science October 18, 2022/ F. Perry Wilson Many People Are Still Infectious on Day 6.Read More
October 11, 2022 Why People Lie About COVID October 11, 2022/ F. Perry Wilson Have you ever lied about COVID-19?Read More
September 28, 2022 A “Bionic Pancreas” for Type 1 Diabetes? September 28, 2022/ F. Perry Wilson New algorithms are changing the landscape of diabetes care, but a “functional cure” remains elusive.Read More
September 21, 2022 To (Bivalent) Boost or Not to Boost September 21, 2022/ F. Perry Wilson The purpose of the updated booster is not only to prevent Omicron infections.Read More